Bacteremia Sepsis Clinical Trial
Official title:
NANO-RAST: Nanomotion-based Resistell AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia and/or Sepsis
Blood culture samples from bacteremia patients positive for Gram-negative bacteria will be tested for antibacterial susceptibility using Resistell Phenotech device. The results will be compared with current AST gold standard tests to calculate sensitivity, specificity, and accuracy of Resistell Phenotech device.
NANO-RAST: Nano-motion based Resistell AST to determine the antibiotic susceptibility of bacteria causing bacteremia and sepsis. Study population: patients admitted at the study site with bacteremia considered to be due to a pathogenic strain (E. coli or K. pneumoniae). Study design: prospective, observational, single arm study. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03611257 -
Effect of dRAST on Treatment for Bacteremia in Patients With Hematologic Diseases
|
N/A | |
| Completed |
NCT03876990 -
Clinical and Medico-economic Evaluation of a Rapid Test (ePlex-BCID®, GenMark) for the Diagnosis of Bacteremia and Fungemia.
|
N/A | |
| Active, not recruiting |
NCT05296590 -
Monocyte Distribution Width (MDW) in the General Population of Emergency Department Patients With and Without Bacteremia
|
||
| Recruiting |
NCT05613322 -
Resistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia
|
||
| Completed |
NCT03577366 -
Prevalence and Characterization of Diagnostic Error Among Patients With Bacteremia
|
||
| Recruiting |
NCT06187168 -
Risk Factors of Post-ERCP Sepsis
|